发明授权
US5886145A Isolated nucleic acid molecules, peptides which form complexes with MHC
molecule HLA-A2 and uses thereof
失效
分离的核酸分子，与MHC分子HLA-A2形成复合物的肽及其用途
- 专利标题： Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
- 专利标题（中）： 分离的核酸分子，与MHC分子HLA-A2形成复合物的肽及其用途
-
申请号： US915972申请日： 1997-08-21
-
公开(公告)号： US5886145A公开(公告)日： 1999-03-23
- 发明人: Yannick Guilloux , Francine Jotereau , Thierry Boon-Falleur , Sophie Lucas , Vincent Brichard
- 申请人： Yannick Guilloux , Francine Jotereau , Thierry Boon-Falleur , Sophie Lucas , Vincent Brichard
- 申请人地址： FRX Paris
- 专利权人： INSERM (Institute National de la Sante et de la Rechereche Medicale)
- 当前专利权人： INSERM (Institute National de la Sante et de la Rechereche Medicale)
- 当前专利权人地址： FRX Paris
- 主分类号： G01N33/50
- IPC分类号： G01N33/50 ; A61K35/26 ; A61K38/00 ; A61K39/00 ; A61K45/00 ; A61K48/00 ; A61P35/00 ; A61P37/04 ; A61P43/00 ; C07K14/47 ; C07K14/74 ; C12N1/15 ; C12N1/19 ; C12N1/21 ; C12N5/10 ; C12N15/09 ; C12N15/12 ; G01N33/15 ; G01N33/53 ; C07H21/04 ; C07K7/06 ; C07K14/705
摘要：
New tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as NAG tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as NAG coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigen precursor molecules are described.
公开/授权文献
信息查询
IPC分类:
